WATERTOWN, Mass., Dec. 5, 2024 /PRNewswire/ — 3D BioLabs LLC (“3D BioLabs” or “3DB”), has reached a pivotal milestone in the field of regenerative medicine as recently published in the Proceedings of the National Academy of Sciences. 3DB’s study has demonstrated a new approach to…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.